| Genetically engineered phages: a review of advances over the last decade DP Pires, S Cleto, S Sillankorva, J Azeredo, TK Lu Microbiology and Molecular Biology Reviews 80 (3), 523-543, 2016 | 456 | 2016 |
| Bacteriophage-encoded depolymerases: their diversity and biotechnological applications DP Pires, H Oliveira, LDR Melo, S Sillankorva, J Azeredo Applied microbiology and biotechnology 100 (5), 2141-2151, 2016 | 433 | 2016 |
| Engineering modular viral scaffolds for targeted bacterial population editing H Ando, S Lemire, DP Pires, TK Lu Cell systems 1 (3), 187-196, 2015 | 381 | 2015 |
| Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections DP Pires, LDR Melo, DV Boas, S Sillankorva, J Azeredo Current opinion in microbiology 39, 48-56, 2017 | 277 | 2017 |
| Phage therapy: going temperate? R Monteiro, DP Pires, AR Costa, J Azeredo Trends in microbiology 27 (4), 368-378, 2019 | 261 | 2019 |
| Phage therapy: a step forward in the treatment of Pseudomonas aeruginosa infections DP Pires, D Vilas Boas, S Sillankorva, J Azeredo Journal of virology 89 (15), 7449-7456, 2015 | 205 | 2015 |
| Current challenges and future opportunities of phage therapy DP Pires, AR Costa, G Pinto, L Meneses, J Azeredo FEMS Microbiology Reviews 44 (6), 684-700, 2020 | 203 | 2020 |
| Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilms D Pires, S Sillankorva, A Faustino, J Azeredo Research in microbiology 162 (8), 798-806, 2011 | 188 | 2011 |
| Phage therapy efficacy: a review of the last 10 years of preclinical studies LDR Melo, H Oliveira, DP Pires, K Dabrowska, J Azeredo Critical reviews in microbiology 46 (1), 78-99, 2020 | 136 | 2020 |
| A genotypic analysis of five P. aeruginosa strains after biofilm infection by phages targeting different cell surface receptors DP Pires, A Dötsch, EM Anderson, Y Hao, CM Khursigara, JS Lam, ... Frontiers in microbiology 8, 1229, 2017 | 64 | 2017 |
| Understanding the complex Phage-Host interactions in biofilm communities DP Pires, LDR Melo, J Azeredo Annual Review of Virology 8, 73-94, 2021 | 54 | 2021 |
| Designing P. aeruginosa synthetic phages with reduced genomes DP Pires, R Monteiro, D Mil-Homens, A Fialho, TK Lu, J Azeredo Scientific reports 11 (1), 1-10, 2021 | 49 | 2021 |
| Pseudomonas Bacteriophage Isolation and Production J Azeredo, S Sillankorva, DP Pires Pseudomonas Methods and Protocols, 23-32, 2014 | 22 | 2014 |
| Exploitation of a Klebsiella Bacteriophage Receptor-Binding Protein as a Superior Biorecognition Molecule CL Nogueira, DP Pires, R Monteiro, SB Santos, CM Carvalho ACS Infectious Diseases, 2021 | 20 | 2021 |
| Differential transcription profiling of the phage LUZ19 infection process in different growth media A Brandão, DP Pires, L Coppens, M Voet, R Lavigne, J Azeredo RNA biology, 1-13, 2021 | 20 | 2021 |
| Complete genome sequence of the Pseudomonas aeruginosa bacteriophage phiIBB-PAA2 DP Pires, AM Kropinski, J Azeredo, S Sillankorva Genome announcements 2 (1), e01102-13, 2014 | 12 | 2014 |
| Unpuzzling friunavirus-host interactions one piece at a time: phage recognizes Acinetobacter pittii via a new K38 capsule depolymerase R Domingues, A Barbosa, SB Santos, DP Pires, J Save, G Resch, ... Antibiotics 10 (11), 1304, 2021 | 11 | 2021 |
| Evaluation of the ability of C. albicans to form biofilm in the presence of phage-resistant phenotypes of P. aeruginosa DP Pires, S Silva, C Almeida, M Henriques, EM Anderson, JS Lam, ... Biofouling 29 (10), 1169-1180, 2013 | 11 | 2013 |
| Phage therapy of infectious biofilms: challenges and strategies LDR Melo, DP Pires, R Monteiro, J Azeredo Phage Therapy: A Practical Approach, 295-313, 2019 | 10 | 2019 |
| In Vitro activity of bacteriophages against planktonic and biofilm populations assessed by flow cytometry DP Pires, LDR Melo Bacteriophage Therapy, 33-41, 2018 | 10 | 2018 |
